Search - tctmd.com

Displaying 101 - 120 of 306

Sort: Relevancy | Date

Presentation TCT 2020

TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR)

Presenter: Jason Nogic

October 14, 2020

Presentation TCT 2020

TCT 304: Meta-Analysis of Long-term Outcomes in Patients With Diabetes Mellitus and Left Main Coronary Artery Disease Treated With Drug-eluting Stent Versus Coronary Artery Bypass Grafting

Presenter: Abdullah Al-abcha

October 14, 2020

Presentation TCT 2020

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

Presenter: Elvin Kedhi

October 14, 2020

Presentation TCT 2020

TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Presenter: Adrian Wlodarczak

October 14, 2020

Presentation ACC 2020

The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: COMPASS Diabetes

Presenter: Deepal L. Bhatt

March 30, 2020

Presentation TCT 2019

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

Presenter: Philippe Genereux

September 29, 2019

Presentation TCT 2019

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

Presenter: Antonio Colombo

September 28, 2019

Presentation TCT 2019

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Presenter: Azeem Latib

September 28, 2019

Presentation TCT 2019

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

Presenter: Roxana Mehran

September 28, 2019

Presentation TCT 2019

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

Leave It to the Endocrinologist!

Presenter: Sonya Burgess

September 27, 2019

Presentation TCT 2019

The Cardiologist Should Play a Major Role in Diabetes Management!

Presenter: Matthew Cavender

September 27, 2019

Presentation TCT 2019

Don't Forget Anticoagulant Therapy!

Presenter: Sanjit Jolly

September 27, 2019

Presentation TCT 2019

The Case for Short-Term (1-6 Months) DAPT

Presenter: Anand Prasad

September 27, 2019

Presentation TCT 2019

The Case for Long-Term (1 Year+) DAPT

Presenter: Usman Baber

September 27, 2019

Presentation TCT 2019

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Presenter: David Kandzari

September 27, 2019

Presentation TCT 2019

Most Contemporary DES Will Provide Similar Outcomes!

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

The Case for PCI in Most!

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

The Case for CABG in Most!

Presenter: Michael Borger

September 27, 2019

Presentation TCT 2019

The Case for Optimal Medical Therapy First in Most!

Presenter: William Boden

September 27, 2019

Advertisement

TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR)

TCT 304: Meta-Analysis of Long-term Outcomes in Patients With Diabetes Mellitus and Left Main Coronary Artery Disease Treated With Drug-eluting Stent Versus Coronary Artery Bypass Grafting

TCT 281: Clinical Outcomes of Optical Coherence Tomography Detected High Risk Versus Low Risk Coronary Atherosclerotic Lesions in Medically Treated Fractional Flow Reserve Negative Lesions in Diabetes Mellitus Patients. The COMBINE Trial.

TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: COMPASS Diabetes

BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI

The ABILITY DIABETES Global Trial: The Largest Randomized Control Trial With Coronary Stents for the Diabetic Population

The ABILITY DIABETES GLOBAL Imaging Study (Randomized Control Trial Comparing Abluminus DES vs. Xience)

Why Do We Need a Dedicated DES for Diabetes?: Introducing the Abluminus Concept

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Leave It to the Endocrinologist!

The Cardiologist Should Play a Major Role in Diabetes Management!

Don't Forget Anticoagulant Therapy!

The Case for Short-Term (1-6 Months) DAPT

The Case for Long-Term (1 Year+) DAPT

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Most Contemporary DES Will Provide Similar Outcomes!

The Case for PCI in Most!

The Case for CABG in Most!

The Case for Optimal Medical Therapy First in Most!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content